Kyowa Hakko Kirin

Japan's Kyowa Kirin reorganizes quality responsibilities
Fierce Pharma
Wed, 11/27/19 - 10:44 am
Japan
Kyowa Hakko Kirin
Parkinson's Disease
pharmacovigilance
Quality Assurance
Nourianz
FDA approves new add-on drug to treat off episodes in adults with Parkinson’s disease
Pharmaceutical Business Review
Wed, 08/28/19 - 10:46 am
Nourianz
Parkinson's Disease
FDA
Kyowa Hakko Kirin
Kyowa Hakko Kirin signs AI drug R&D deal with InveniAI
Pharmaforum
Fri, 01/11/19 - 09:54 am
artificial intelligence
machine learnings
InveniAI
Kyowa Hakko Kirin
drug discovery
FDA Approves Eight Novel Drugs in August
BioSpace
Sat, 09/1/18 - 04:17 pm
Kyowa Hakko Kirin
Poteligeo
Alnylam
Onpattro
Amicus Therapeutics
Galafold
TherapeuticMD
Annovera
Biocodex
Diacomit
Dompe Group
Oxervate
Shire
Takhzyro
Merck
Pifeltro
After seeing POC data, Kyowa advances Parkinson’s program despite being dropped by Lundbeck
Fierce Biotech
Mon, 08/20/18 - 10:08 am
Kyowa Hakko Kirin
Parkinson's Disease
KW-6356
Lundbeck
Coffee Fuels Drive for Drugs for Parkinson’s to Dementia
Bloomberg
Mon, 03/17/14 - 08:34 am
caffeine
Parkinson's Disease
Merck
Kyowa Hakko Kirin
Nouriast
Daiichi Sankyo, Kyowa Hakko Signal More Japanese Drug Takeovers
Bloomberg
Wed, 03/2/11 - 10:33 am
Japan
Kyowa Hakko Kirin
Daiichi Sankyo
Plexxikon
Prostrakan
M&A
M&A fills patent holes, fuels geographic expansion
Fierce Pharma
Wed, 02/23/11 - 08:55 am
M&A
patents
Kyowa Hakko Kirin
Prostrakan
Forest Labs
Clinical Data
Amoun
Biotech's Biggest R&D Spenders 2010
Fierce Biotech
Mon, 11/22/10 - 10:45 am
biotech
R&D
Amgen
Biogen Idec
Gilead Sciences
Genzyme
Celgene
Kyowa Hakko Kirin
Vertex Pharmaceuticals
Life Technologies
CSL
Amylin
Genmab
Cubist Pharmaceuticals
MannKind
companies
Merial
Biovail Enters into License Agreement with Kyowa Hakko Kirin
Pipeline Review
Sat, 06/5/10 - 12:00 pm
Biovail
Kyowa Hakko Kirin
Parkinson's Disease
Istradefylline